Evidence map›Paper›PMID 25765020›Full record

ArticleBMJ open2015

Cross-sectional comparison of point-of-care with laboratory HbA₁c in detecting diabetes in real-world remote Aboriginal settings.

Julia V Marley, May S Oh, Nyssa Hadgraft, Sally Singleton, Kim Isaacs, David Atkinson

Abstract readComparative Study
In one paragraph

Article in BMJ open, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Community-Based Diabetes Awareness Strategy With Detection and Intervention: The Mobile Diabetes Education Center.Clinical diabetes : a publication of the American Diabetes Association · 2024
    Article
  3. Article
  4. Article
  5. Diagnostic Accuracy of Glycated Haemoglobin and Average Glucose Values in Type 2 Diabetes Mellitus Treated with Premixed Insulin.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2019
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julia V MarleyThe Rural Clinical School of Western Australia, The University of Western Australia, Broome, Western Australia, Australia Kimberley Aboriginal Medical Services Council, Broome, Western Australia, Australia.
May S OhKimberley Aboriginal Medical Services Council, Broome, Western Australia, Australia.
Nyssa HadgraftKimberley Aboriginal Medical Services Council, Broome, Western Australia, Australia.
Sally SingletonKimberley Aboriginal Medical Services Council, Broome, Western Australia, Australia.
Kim IsaacsKimberley Aboriginal Medical Services Council, Broome, Western Australia, Australia.
David AtkinsonThe Rural Clinical School of Western Australia, The University of Western Australia, Broome, Western Australia, Australia Kimberley Aboriginal Medical Services Council, Broome, Western Australia, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine if point-of-care (POC) glycated haemoglobin (HbA₁c) is sufficiently accurate in real-world remote settings to predict or exclude the diagnosis of diabetes based on laboratory HbA1c measurements.

designCross-sectional study comparing POC capillary HbA₁c results with corresponding venous HbA₁c levels measured in a reference laboratory.

participantsAboriginal patients ≥15 years old who were due for diabetes screening at the participating clinics were invited to participate. Two hundred and fifty-five Aboriginal participants were enrolled and 241 were included in the analysis.

setting6 primary healthcare sites in the remote Kimberley region of Western Australia from September 2011 to November 2013.

main outcome measuresConcordance and mean differences between POC capillary blood HbA₁c measurement and laboratory measurement of venous blood HbA₁c level; POC capillary blood HbA1c equivalence value for screening for diabetes or a high risk of developing diabetes; sensitivity, specificity and positive-predictive value for diagnosing and screening for diabetes; barriers to conducting POC testing.

resultsConcordance between POC and laboratory results was good (ρ=0.88, p<0.001). The mean difference was -0.15% (95% limits of agreement, -0.67% to 0.36%). POC HbA₁c measurements ≥6.5%, 48 mmol/mol had a specificity of 98.2% and sensitivity of 73.7% for laboratory measurements ≥6.5%. The POC equivalence value for screening for diabetes or a high risk of developing diabetes was ≥5.7%, 39 mmol/mol (sensitivity, 91%; specificity, 76.7% for laboratory measurements ≥6.0%, 42 mmol/mol). Staff trained by other clinic staff 'on the job' performed as well as people with formal accredited training. Staff reported difficulty in maintaining formal accreditation.

conclusionsPOC HbA₁c testing is sufficiently accurate to be a useful component in screening for, and diagnosing, diabetes in remote communities. Limited local training is adequate to produce results comparable to laboratory results and accreditation processes need to reflect this.

Indexed as

Blood GlucoseClinical Laboratory TechniquesCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansMaleNational Health ProgramsPoint-of-Care SystemsReproducibility of ResultsRural Health ServicesWestern AustraliaBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanAboriginaldiabetes screeningHbA1cpoint-of-care testing

Identifiers

PMID25765020
PMCPMC4360580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.